Accesso libero

Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway

Qing Su

Qing Su

Department of Orthopedic Oncology, Yantai Shan HospitalYantai, China
Cerca questo autore su
Sciendo|Google Scholar
Su, Qing
, 
Baolin Xu

Baolin Xu

Department of Orthopedics, The Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, China
Cerca questo autore su
Sciendo|Google Scholar
Xu, Baolin
, 
Zhoubin Tian

Zhoubin Tian

Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinan, China
Cerca questo autore su
Sciendo|Google Scholar
Tian, Zhoubin
 e 
Ziling Gong

Ziling Gong

Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalShanghai, China
Cerca questo autore su
Sciendo|Google Scholar
Gong, Ziling
  
13 apr 2022
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Pubblicato online: 13 apr 2022
Pagine: 389 - 402
Accettato: 14 dic 2021
DOI: https://doi.org/10.2478/acph-2022-0026
Parole chiave
© 2022 Qing Su et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Farmacia, Farmacia, altro
Feed RSS della rivista